CUAMC
UTHR icon

China Universal Asset Management Company’s United Therapeutics UTHR Stock Holding History

China Universal Asset Management Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.66M Sell
6,755
-1,023
-13% -$576K 0.22% 78
2026
Q1 		$4.61M Buy
7,778
+262
+3% +$130K 0.35% 58
2025
Q4 		$3.66M Sell
7,516
-2,411
-24% -$1.12M 0.28% 64
2025
Q3 		$4.16M Buy
9,927
+868
+10% +$292K 0.34% 61
2025
Q2 		$2.6M Buy
9,059
+50
+0.6% +$14.9K 0.24% 86
2025
Q1 		$2.78M Sell
9,009
-457
-5% -$157K 0.26% 83
2024
Q4 		$3.34M Buy
9,466
+909
+11% +$334K 0.31% 68
2024
Q3 		$3.07M Buy
8,557
+3,344
+64% +$1.13M 0.34% 64
2024
Q2 		$1.66M Sell
5,213
-3,827
-42% -$1.01M 0.23% 80
2024
Q1 		$2.08M Buy
9,040
+3,603
+66% +$813K 0.26% 80
2023
Q4 		$1.2M Buy
5,437
+4,240
+354% +$977K 0.23% 95
2023
Q3 		$270K Buy
1,197
+582
+95% +$134K 0.08% 131
2023
Q2 		$136K Sell
615
-13
-2% -$2.88K 0.04% 146
2023
Q1 		$141K Buy
628
+165
+36% +$40.7K 0.05% 124
2022
Q4 		$129K Buy
463
+37
+9% +$9.34K 0.05% 115
2022
Q3 		$89K Buy
+426
New +$95.2K 0.04% 114

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

China Universal Asset Management Company's UTHR Position: Q2 2026 in Review

China Universal Asset Management Company reduced its United Therapeutics (UTHR) stake by 13% in Q2 2026, selling an estimated $576K and leaving 6,755 shares worth $3.66M. The position accounts for 0.22% of the portfolio, ranked #78.

China Universal Asset Management Company first reported a position in UTHR in Q3 2022 and has held it in 16 quarters since. The position peaked at $4.61M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • China Universal Asset Management Company held 6,755 shares of United Therapeutics worth $3.66M as of Q2 2026.
  • China Universal Asset Management Company sold 1,023 United Therapeutics shares in Q2 2026, an estimated $576K.
  • United Therapeutics made up 0.22% of China Universal Asset Management Company's portfolio in Q2 2026, its #78 holding.
  • China Universal Asset Management Company first reported a position in United Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's United Therapeutics position peaked at $4.61M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.